CD4 and neoplasm: In contrast to the spleen and TDLNs, there was almost a complete lack of naïve CD4+ T cells in the control tumor, a situation that was reversed by all 3 types of therapy, with IGRT/TAT/immunocytokine therapy exhibiting the most dramatic increase (Fig. 6E).